Misoprostol Tablets 200mg together use with Mifepristone tablet
[Drug name] Misoprostol Tablets
[Ingredients] The main ingredient of this product is misoprostol. Its chemical name is: (±) (11a, 13E) - 11,16<br/>Dihydroxy-16-methyl prostane-9-keto-13-en-1-carboxylic acid methyl ester< Br/>Molecular formula: C22H38O5<br/>Molecular weight: 382.54</p>
[Character] This product is white tablets.
[Indications] This product can be used in combination with mifepristone in sequence to terminate early pregnancy within 49 days after menopause.
[Usage and dosage] After taking mifepristone for 36~48 hours, take a single oral dose of misoprostol 0.6 mg on an empty stomach.
[Adverse reaction] Some early pregnant women have mild nausea, vomiting, dizziness, fatigue and lower abdominal pain after taking the medicine. And individual women may have flushing, fever, pruritus in palms, and even anaphylactic shock.
[Contraindication] 1. Patients with heart, liver and kidney diseases and adrenal cortex insufficiency. 2. Those who have contraindications to use prostaglandins, such as glaucoma, asthma and allergic constitution. 3. Pregnancy with IUD and suspected ectopic pregnancy.
[Precautions] 1. When this product is used to terminate early pregnancy, it must be compatible with mifepristone. It is strictly prohibited to use alone. 2. When this product is used in combination with mifepristone to terminate early pregnancy, it must be prescribed by a doctor and used by an organization with emergency curettage, transfusion and blood transfusion conditions under the supervision of a doctor. This product cannot be sold in the pharmacy. 3. Before taking the medicine, the user must be informed of the treatment effect and possible side effects. In the process of treatment or follow-up, if there is a large amount of bleeding or other abnormal conditions, seek medical advice in time. 4. After taking the medicine, a small amount of vaginal bleeding usually occurs earlier, and some women have a longer bleeding time after abortion. A few early pregnant women can have spontaneous abortion after taking mifepristone. About 80% of pregnant women will discharge the chorionic sac within 6 hours after using this product. About 10% of pregnant women excrete the pregnant substance within one week after taking the medicine.
[Medication for special population]
Precautions for children:
Not yet clear.
Precautions during pregnancy and lactation:
1. Prohibited for pregnant women; 2. Breastfeeding women should not take it.
Precautions for the elderly:
Not yet clear.
[Drug interaction] Avoid taking aspirin and other non steroidal anti-inflammatory drugs within one week after taking this product.
[Pharmacological effect] Drugs for terminating early pregnancy. This product has the functions of softening cervix, enhancing uterine tension and intrauterine pressure. The sequential combination of mifepristone and mifepristone can significantly increase or induce the frequency and amplitude of spontaneous uterine contraction in early pregnancy. This product has the pharmacological activity of E-type prostaglandin, and has a slight stimulation effect on gastrointestinal smooth muscle, and inhibits gastric acid secretion in large doses.
[Storage] Sealed storage.
[Specification] 0.2mg
[Packaging specification] Composite aluminum plastic packaging, 3 pieces per plate, 1 plate per box.
[Validity] 24 months
Audited Supplier 
){kind=link}
){kind=link}